Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MINNEAPOLIS, May 12, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets... | May 12, 2023
Bio-Techne Co. (NASDAQ:TECH – Get Rating) announced a quarterly dividend on Wednesday, May 3rd, Zacks reports. Investors of record on Monday, May 15th will be given a dividend of 0.08 per share by the biotechnology company on Friday, May 26th. This represents a $0.32 dividend on an annualized basis and a yield of 0.39%. The […]
California Public Employees Retirement System increased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 302.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 348,072 shares of the biotechnology company’s stock after purchasing an additional 261,515 shares during the quarter. California Public Employees […]
Bio-Techne (NASDAQ:TECH – Get Rating) had its price objective increased by Robert W. Baird from $99.00 to $100.00 in a report released on Thursday, The Fly reports. Other equities research analysts have also recently issued research reports about the stock. SVB Leerink cut their price objective on shares of Bio-Techne from $125.00 to $110.00 and […]
Aziyo Biologics (NASDAQ:AZYO – Get Rating) and Bio-Techne (NASDAQ:TECH – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Aziyo Biologics and Bio-Techne’s revenue, […]